Skip to main content

Fennec Pharmaceuticals Inc.

FENC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001211583

In the last 90 days, Fennec Pharmaceuticals Inc. insiders filed 0 open-market purchases and 6 sales; 105 institutions reported holding it in 13F filings for Q2 2026, worth $175.1M in total; no superinvestor holds it.

13F holders, Q1 2022

Institutional positions in Fennec Pharmaceuticals Inc. as of Mar 31, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
28
−2 vs. Q4 2021
Shares held
11.4M
+90.4K (+0.8%) vs. Q4 2021
Total value
$64.1M
+$14.1M (+28.3%) vs. Q4 2021
New holders
1
8 more added
Sold out
3
9 more reduced

Compare with Q4 2021: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting FENC on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ1 2022: 28 institutions
Q1 2021: 53 institutionsQ2 2021: 39 institutionsQ3 2021: 32 institutionsQ4 2021: 30 institutionsQ1 2022: 28 institutionsQ2 2022: 28 institutionsQ3 2022: 31 institutionsQ4 2022: 43 institutionsQ1 2023: 54 institutionsQ2 2023: 56 institutionsQ3 2023: 55 institutionsQ4 2023: 56 institutionsQ1 2024: 65 institutionsQ2 2024: 64 institutionsQ3 2024: 63 institutionsQ4 2024: 64 institutionsQ1 2025: 68 institutionsQ2 2025: 78 institutionsQ3 2025: 84 institutionsQ4 2025: 96 institutionsQ1 2026: 90 institutionsQ2 2026: 105 institutions
Value heldQ1 2022: $64.1M
Q1 2021: $89.3MQ2 2021: $88.0MQ3 2021: $109.7MQ4 2021: $49.9MQ1 2022: $64.1MQ2 2022: $63.2MQ3 2022: $92.1MQ4 2022: $119.5MQ1 2023: $108.5MQ2 2023: $124.5MQ3 2023: $107.6MQ4 2023: $168.4MQ1 2024: $161.1MQ2 2024: $87.7MQ3 2024: $74.6MQ4 2024: $101.4MQ1 2025: $81.6MQ2 2025: $112.9MQ3 2025: $129.8MQ4 2025: $119.6MQ1 2026: $99.6MQ2 2026: $175.1M
Institutions holding FENC and their total value by quarter
QuarterHoldersValue
Q2 2026105$175.1M
Q1 202690$99.6M
Q4 202596$119.6M
Q3 202584$129.8M
Q2 202578$112.9M
Q1 202568$81.6M
Q4 202464$101.4M
Q3 202463$74.6M
Q2 202464$87.7M
Q1 202465$161.1M
Q4 202356$168.4M
Q3 202355$107.6M
Q2 202356$124.5M
Q1 202354$108.5M
Q4 202243$119.5M
Q3 202231$92.1M
Q2 202228$63.2M
Q1 202228$64.1M
Q4 202130$49.9M
Q3 202132$109.7M
Q2 202139$88.0M
Q1 202153$89.3M

Institutions, Q1 2022

Shares, value and share of portfolio for each institution holding Fennec Pharmaceuticals Inc.; share changes are against Q4 2021.

Institutions holding FENC in Q1 2022
InstitutionSharesValue% of portfolioChange in sharesAction
Southpoint Capital Advisors LP4,077,214$22.8M0.44%00.0%Unchanged
Sonic Fund II, L.P.2,407,357$13.5M7.57%00.0%Unchanged
DG Capital Management, LLC1,210,638$6.78M1.37%+51,249+4.4%Added
Avoro Capital Advisors LLC1,200,000$6.72M0.12%00.0%Unchanged
Solas Capital Management, LLC1,145,796$6.42M3.89%+277,939+32.0%Added
683 Capital Management, LLC484,318$2.71M0.16%−224,982−31.7%Reduced
Millennium Management LLC252,679$1.42M0.00%−4,938−1.9%Reduced
Harbert Fund Advisors, Inc.189,750$1.06M0.55%00.0%Unchanged
Susquehanna International Group, LLP133,964$750.0K0.00%−137−0.1%Reduced
BlackRock Inc.55,339$310.0K0.00%−2,160−3.8%Reduced
Tamar Securities, LLC53,475$299.0K0.08%00.0%Unchanged
Morgan Stanley50,180$281.0K0.00%+9,171+22.4%Added
Valley Forge Investment Consultants Inc Adv40,000$224.0K0.09%00.0%Unchanged
Hartford Financial Management Inc.34,848$195.0K0.05%00.0%Unchanged
Wealthspire Advisors, LLC25,000$140.0K0.00%00.0%Unchanged
Geode Capital Management, LLC19,507$109.0K0.00%−112−0.6%Reduced
JPMorgan Chase & Co16,366$91.0K0.00%+16,296+23,280.0%Added
Goldman Sachs Group Inc13,080$73.0K0.00%−368−2.7%Reduced
Advisor Group Holdings, Inc.11,220$63.0K0.00%+250+2.3%Added
Ancora Advisors, LLC6,000$34.0K0.00%00.0%Unchanged
Bank of America Corp4,961$28.0K0.00%−6,422−56.4%Reduced
BNP Paribas Arbitrage, SA3,456$19.4K0.00%+3,224+1,389.7%Added
Fortitude Advisory Group L.L.C.1,500$8.00K0.00%00.0%Unchanged
UBS Group AG1,096$6.00K0.00%−6,681−85.9%Reduced
Tower Research Capital LLC (TRC)138$1.00K0.00%−5,832−97.7%Reduced
Royal Bank of Canada111$1.00K0.00%+94+552.9%Added
FMR LLC112$1.00K0.00%+112New
Toronto Dominion Bank71$00.00%+17+31.5%Added
Citadel Advisors LLC0$00.00%−14,874−100.0%Sold out
Simplex Trading, LLC0$00.00%−899−100.0%Sold out
TD Waterhouse Canada Inc.0$00.00%−555−100.0%Sold out